Global Vascular Network (GVN), conceptualized and established by Professor Chang Shu at the 2023 China Vascular Congress (CVC), was founded with the mission to pool global expertise and advance collaboration and innovation in vascular surgery.
As its overseas academic platform----Vasco Knight, has been actively cooperate with global symposiums on exchange activities over recent years, such as VEITH , LINC ,SITE , ASVS...
Vasco Knight provides you with a platform to share the breakthroughs and innovative achievements you have made in clinical practice. Through communication and sharing, doctors can draw on valuable experience, thereby better serving patients and promoting the continuous progress of vascular interventional therapy. Meanwhile, Vasco Knight is also a window to showcase the strength of Chinese vascular doctors.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 203 Marsh Wall, Flat 4206 Amory Tower,united Kingdom
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.vascularknight.com
- Keywords
- incubation, high-tech medical equipment sector, advanced technology incubation, cutting-edge market solutions, services for medical device companies, delivering innovative solutions, fostering technological progress, medical innovation, investment, research and development, market promotion, healthcare advancement.
- HQ
- London, England
Vasco Knight Questions
Vasco Knight's website is http://www.vascularknight.com
Vasco Knight's LinkedIn profile is https://uk.linkedin.com/company/vascoknight
Vasco Knight has
3 employees.
View email and phone details for 3
employees at Vasco Knight.
Vasco Knight's industry is
Hospitals and Health Care
Vasco Knight's top competitors are
Columbia Global Centers | Nairobi,
Guidehouse,
Axa Med,
Ridgeline Health Group,
Spring Health,
Medbridge Healthcare,
Sachs Policy Group,
Evolent,
Audacity, Bangkok,
Medbridge Medical.
Vasco Knight's categories are Hospitals and Health Care
Vasco Knight's founding year is 2023
